Abbott has decided to initiate a voluntary field action for all lot numbers of heartmate iii distributed since september 2014.Internal investigation performed by abbott has determined there is a potential for an outflow graft occlusion due to twisting.Abbott performed a comprehensive investigation which included device analysis, manufacturing evaluation and trend analysis.The root cause identification determined that bend relief rotation is inconsistently translated to the outflow graft hardware.A risk/benefit analysis was performed and it was determined that despite the potential for an outflow graft occlusion due to twisting, the associated residual risks are low and are considered acceptable.As a corrective action, consignees have been notified of the potential occlusion due to twisting.Additionally, abbott will continue to trend complaints related to this event based on original event description and/or results of product evaluation.
|
A complaint trend was identified as possibly related to hm3 outflow graft obstruction due to twisting.These complaints were investigated as part of a capa since they documented persistent, post-operative low flows and reported outflow graft deformation potentially from a twist anywhere along the graft.These complaints were confirmed based on available data from reoperation with visualization or ct angiography, or through explant analysis confirming hm3 outflow graft obstruction due to postoperative twisting.
|